Bing Ma Selected Research

Acetazolamide (Diamox)

7/2004	The protein profile of acetazolamide-treated sera in mice bearing Lewis neoplasm.
6/2004	Acetazolamide inhibits aquaporin-1 protein expression and angiogenesis.
8/2002	Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Ma Research Topics

Disease

43	Neoplasms (Cancer) 01/2024 - 08/2002
30	Inflammation (Inflammations) 04/2024 - 03/2002
20	Burns 01/2022 - 12/2004
17	Wounds and Injuries (Trauma) 01/2024 - 12/2004
16	Infections 02/2022 - 11/2007
13	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2002
9	Fibrosis (Cirrhosis) 01/2020 - 03/2002
7	COVID-19 01/2023 - 01/2021
7	Sepsis (Septicemia) 01/2022 - 02/2010
7	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 04/2016
7	Asthma (Bronchial Asthma) 04/2015 - 07/2002
6	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2008
6	Cicatrix (Scar) 01/2022 - 02/2002
6	Melanoma (Melanoma, Malignant) 01/2022 - 05/2012
6	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2021 - 02/2002
6	Diabetes Complications 11/2020 - 12/2011
6	Lung Injury 01/2016 - 04/2005
5	Pneumonia (Pneumonitis) 03/2021 - 03/2002
5	Lewis Lung Carcinoma 08/2011 - 08/2002
4	Hypertension (High Blood Pressure) 10/2023 - 04/2017
4	Stroke (Strokes) 01/2021 - 04/2017
4	Acute Lung Injury 11/2014 - 04/2005
4	Metaplasia 11/2011 - 03/2002
3	Alopecia (Baldness) 06/2023 - 01/2008
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2023 - 01/2019
3	Residual Neoplasm 12/2021 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2014
3	Gout 11/2017 - 09/2014
3	Pathologic Complete Response 12/2011 - 12/2011
3	Edema (Dropsy) 11/2011 - 07/2006
3	Shock 06/2010 - 04/2007
3	Respiratory Hypersensitivity 11/2007 - 07/2002
2	Hemorrhage 01/2024 - 01/2022
2	Jaundice (Icterus) 01/2024 - 03/2022
2	Pathologic Processes 10/2023 - 12/2006
2	Liver Diseases (Liver Disease) 03/2022 - 12/2012
2	Diabetes Mellitus 01/2022 - 09/2014

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2002
16	ChitinasesIBA 05/2023 - 01/2011
13	CytokinesIBA 01/2022 - 03/2003
10	Interleukin-13IBA 09/2015 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2011
7	HydrogelsIBA 10/2023 - 01/2011
7	Biocompatible Materials (Biomaterials)IBA 06/2023 - 01/2019
6	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 02/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2005
6	Messenger RNA (mRNA)IBA 08/2011 - 02/2002
5	IonsIBA 06/2023 - 09/2015
5	Therapeutic UsesIBA 03/2022 - 01/2019
5	EnzymesIBA 03/2022 - 08/2002
5	Aldehyde Reductase (Aldose Reductase)IBA 01/2022 - 12/2011
5	AntibodiesIBA 01/2022 - 02/2014
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2009
5	Small Interfering RNA (siRNA)IBA 10/2018 - 06/2011
4	Matrix Metalloproteinases (MMPs)IBA 09/2021 - 08/2002
4	Oxidants (Oxidizing Agents)IBA 01/2016 - 04/2005
4	Docetaxel (Taxotere)FDA Link 12/2011 - 01/2008
4	Epirubicin (Ellence)FDA LinkGeneric 12/2011 - 01/2008
4	ChemokinesIBA 01/2006 - 03/2002
3	SaltsIBA 10/2023 - 01/2021
3	SodiumIBA 10/2023 - 10/2005
3	CreatinineIBA 01/2023 - 02/2010
3	VaccinesIBA 01/2023 - 01/2016
3	C-Reactive ProteinIBA 11/2022 - 01/2022
3	AntigensIBA 03/2022 - 11/2015
3	polyolIBA 01/2022 - 11/2020
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2006
3	CollagenIBA 01/2022 - 02/2010
3	Toll-Like Receptor 4IBA 12/2021 - 05/2012
3	LigandsIBA 11/2021 - 05/2018
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2006
3	InterleukinsIBA 01/2018 - 07/2002
3	RNA (Ribonucleic Acid)IBA 12/2017 - 12/2004
3	Xanthine OxidaseIBA 11/2017 - 09/2014
3	LipopolysaccharidesIBA 11/2015 - 04/2014
3	InterferonsIBA 03/2012 - 12/2004
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2010 - 05/2006
3	Acetazolamide (Diamox)FDA LinkGeneric 07/2004 - 08/2002
2	NanogelsIBA 01/2024 - 12/2023
2	BilirubinIBA 01/2024 - 03/2022
2	SolutionsIBA 11/2023 - 01/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023 - 07/2006
2	ZincIBA 06/2023 - 09/2021
2	QuercetinIBA 06/2023 - 01/2022
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2023 - 02/2010
2	Peptides (Polypeptides)IBA 05/2023 - 12/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 01/2021
2	kasugamycinIBA 02/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2021
2	Bispecific AntibodiesIBA 01/2022 - 11/2021

Therapy/Procedure

25	Therapeutics 01/2024 - 04/2007
6	Neoadjuvant Therapy 01/2015 - 01/2008
6	Resuscitation 12/2012 - 10/2005
4	Immunotherapy 05/2023 - 12/2020
3	Length of Stay 01/2022 - 11/2007
3	Ligation 11/2015 - 09/2010
2	Aftercare (After-Treatment) 04/2024 - 03/2012
2	Organ Transplantation 12/2023 - 09/2023